Endocrine Testing Market Will Grow at a Steady Rate of 8.0% from 2013 to 2024: Grand View Research, Inc.
The
global endocrine testing market is expected to reach USD 13.02
billion by 2024, according to a new report by Grand View Research, Inc.
Increasing geriatric population and growing rate of diseases such as obesity
and diabetes is expected to drive the market growth.
The
presence of a large population over 60 years, having lower immunity levels and
are prone to neurological diseases, cardiac problems, cancers, and spinal
injuries, is a high impact-rendering driver for the growth of endocrine testing
market over the forecast period.
Sedentary
lifestyles of people with unhealthy food habits and increasing stress levels
resulted in an increase in the diabetic and obese population. This demographic
is highly susceptible to endocrine diseases and is anticipated to contribute to
industry growth substantially.
Technological
advancements in terms of accuracy and affordability resulted in an increased
usage of these tests. For instance, the influx of test kits, for home-based
testing has fostered the demand for these techniques, helping the market to
grow. Advancement in technology ensures diagnosis in less time and faster
initiation of treatment.
Software
have been designed to manage the workflow in the laboratories. Newer mobile
apps have been introduced wherein a patient can be reminded about his
appointment or test, and he will be able to contact physician whenever he
wants. These advancements in technology is anticipated to propel the market
growth over the forecast period.
Browse full
research report on Endocrine Testing Market: www.grandviewresearch.com/industry-analysis/endocrine-testing-market
Further
key findings from the study suggest:
- The global thyroid stimulating hormone testing
market is anticipated to reach 3.6 billion by 2024, at a CAGR of 10.2%
from 2016 to 2024
- In terms of test type, insulin test is expected
to show the fastest growth over the forecast period
- In terms of technology, Tandem Mass
Spectrometry (TMS) held the largest share in 2016 and is expected to
dominate the market during the forecast period
- In terms of technology, sensor technology is
expected to show the fastest growth during the forecast period
- North America is expected to dominate the
market followed by Europe and Asia Pacific region
- Asia Pacific is projected to drive the market
growth and provide numerous opportunities to industry players. Key factors
attributed to market growth include growing R&D expenditure by the
government and private agencies in order to improve diagnostic and therapeutic
areas in the region
- Some of the key companies present in the market
include Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical
Technologies, bioMerieux SA, Bio Rad Laboratories, DiaSorin, Hoffmann-La
Roche Ltd., LabCorp, and Quest Diagnostics.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global endocrine testing market
report on the basis of test type, technology, end use, and region:
Test Type
Outlook (Revenue, USD Million, 2013 - 2024)
- Estradiol
- FSH
- hCG
- LH
- DHEAS
- Progesterone
- Testosterone
- TSH
- Prolactin
- Cortisol
- Insulin
- Others
Technology
Outlook (Revenue, USD Million, 2013 - 2024)
- Tandem
Mass Spectrometry
- Immunoassay
- Monoclonal
& Polyclonal antibody technologies
- Sensor
technology
- Clinical
chemistry
- Others
End Use
Outlook (Revenue, USD Million, 2013 - 2024)
- Hospital
- Commercial
Laboratory
- Ambulatory
Care Centers
- Others
Regional
Outlook (Revenue, USD Million, 2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-endocrine-testing-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment